Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden

[1]  E. Berardesca,et al.  Biologic Therapies for Psoriasis , 2009, The Journal of Rheumatology.

[2]  G. Favato.  High incidence of smoking habit in psoriatic patients. , 2008, The American journal of medicine.

[3]  C. Ritchlin.  Psoriatic disease—from skin to bone , 2007, Nature Clinical Practice Rheumatology.

[4]  James T. Elder,et al.  Psoriasis: epidemiology. , 2007, Clinics in dermatology.

[5]  A. Gottlieb,et al.  Biologic therapies for psoriasis. A systematic review. , 2006, The Journal of rheumatology.

[6]  T. Schäfer,et al.  Epidemiology of Psoriasis , 2006, Dermatology.

[7]  G. Krueger,et al.  Psoriasis--recent advances in understanding its pathogenesis and treatment. , 2005, Journal of the American Academy of Dermatology.

[8]  M. Lebwohl.  A clinician's paradigm in the treatment of psoriasis. , 2005, Journal of the American Academy of Dermatology.

[9]  P. Boffetta,et al.  Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden. , 2001, The Journal of investigative dermatology.

[10]  R. Zachariae,et al.  Treatment of psoriasis in the Nordic countries: a questionnaire survey from 5739 members of the psoriasis associations data from the Nordic Quality of Life Study. , 2001, Acta dermato-venereologica.

[11]  P. Simpson,et al.  Statistical methods in cancer research , 2001, Journal of surgical oncology.

[12]  A. Hannuksela-Svahn,et al.  Psoriasis, its treatment, and cancer in a cohort of Finnish patients. , 2000, The Journal of investigative dermatology.

[13]  J. Karvonen,et al.  Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. , 1999, Archives of dermatology.

[14]  G. Frentz,et al.  Malignant tumours and psoriasis: a follow‐up study , 1999, The British journal of dermatology.

[15]  Félix Arellano,et al.  Risk of cancer with cyclosporine in psoriasis , 1997, International journal of dermatology.

[16]  J. Karvonen,et al.  Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA. , 1996, Journal of the American Academy of Dermatology.

[17]  J. Ortonne,et al.  Aetiology and pathogenesis of psoriasis , 1996, The British journal of dermatology.

[18]  J. Voorhees,et al.  Psoriasis, T Cells and Autoimmunity , 1996, Journal of the Royal Society of Medicine.

[19]  C. Patterson,et al.  Cutaneous neoplasia following PUVA therapy for psoriasis , 1996, The British journal of dermatology.

[20]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[21]  D. Duffy,et al.  Psoriasis in Australian twins. , 1993, Journal of the American Academy of Dermatology.

[22]  L. Naldi,et al.  Family history, smoking habits, alcohol consumption and risk of psoriasis , 1992, The British journal of dermatology.

[23]  Matthew D. Schultz,et al.  PUVA and skin cancer. A historical cohort study on 492 patients. , 1992, Journal of the American Academy of Dermatology.

[24]  T. Reunala,et al.  Alcohol intake: a risk factor for psoriasis in young and middle aged men? , 1990, BMJ.

[25]  A. Kimball,et al.  The Psychosocial Burden of Psoriasis , 2005, American journal of clinical dermatology.

[26]  B. Lindegård.  Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. , 1986, Dermatologica.

[27]  H. E. Hansen,et al.  Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution. , 1982, Acta dermato-venereologica.